Furthermore, dPCR presents limitations, along with the divergence between tumor tissue and ctDNA, as reported here and for MYCN status in patients with neuroblastoma [53], 1q status and Wilms tumors [42,54] and others. The gene discussed is MYCN; the disease is Nephroblastoma.